Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosis

Autor: Chhibber, Anindit, Watanabe, Alexandre Hikiji, Jacobs, Hollyann, Kharat, Aditi, Syeed, Sakil M., Sherwin, Catherine M., Chaiyakunapruk, Nathorn, Biskupiak, Joseph, Yellepeddi, Venkata K., Brixner, Diana, Young, David C.

Publikováno v: In Journal of Cystic Fibrosis September 2024 23(5):1010-1019

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis.

Autor: Kormelink LN; Department of Pharmacy, University of Kentucky Healthcare, Lexington, Kentucky, USA.; Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, Kentucky, USA., Jacobs HR; Department of Pharmacy, University of Utah Health, Salt Lake City, Utah, USA.

Publikováno v: Pediatric pulmonology [Pediatr Pulmonol] 2024 Dec 02, pp. e27431. Date of Electronic Publication: 2024 Dec 02.